Publicaciones en colaboración con investigadores/as de University of California, San Diego (44)

2025

  1. Collaborative outcomes study on health and functioning during infection times (COH-FIT): Insights on modifiable and non-modifiable risk and protective factors for wellbeing and mental health during the COVID-19 pandemic from multivariable and network analyses

    European Neuropsychopharmacology, Vol. 90, pp. 1-15

2024

  1. A novel gene editing lexicon strategy for the haemophilia community: Research plan for development and preliminary results

    Haemophilia

  2. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  3. Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study

    The Lancet Oncology, Vol. 25, Núm. 5, pp. 668-682

  4. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

    Scientific Reports

  5. GLABRA2 transcription factor integrates arsenic tolerance with epidermal cell fate determination

    New Phytologist

  6. Global and risk-group stratified well-being and mental health during the COVID-19 pandemic in adults: Results from the international COH-FIT Study

    Psychiatry Research, Vol. 342

  7. Recommendations for quantitative cerebral perfusion MRI using multi-timepoint arterial spin labeling: Acquisition, quantification, and clinical applications

    Magnetic Resonance in Medicine, Vol. 92, Núm. 2, pp. 469-495

  8. Stroke in critically ill patients with respiratory failure due to COVID-19: Disparities between low-middle and high-income countries

    Heart and Lung, Vol. 68, pp. 131-144

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. In situ tumour arrays reveal early environmental control of cancer immunity

    Nature, Vol. 618, Núm. 7966, pp. 827-833

  3. Initial Evidence for the Efficacy of Naporafenib in Combination With Trametinib in NRAS -Mutant Melanoma: Results From the Expansion Arm of a Phase Ib, Open-Label Study

    Journal of Clinical Oncology, Vol. 41, Núm. 14, pp. 2651-2660

  4. Transoral awake state neuromuscular electrical stimulation therapy for mild obstructive sleep apnea

    Sleep and Breathing, Vol. 27, Núm. 2, pp. 527-534

  5. Validation of the Collaborative Outcomes study on Health and Functioning during Infection Times (COH-FIT) questionnaire for adults

    Journal of Affective Disorders, Vol. 326, pp. 249-261

2022

  1. Clinical, histological and molecular profiling of different stages of alcohol-related liver disease

    Gut, Vol. 71, Núm. 9, pp. 1856-1866

  2. Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis

    Critical Care, Vol. 26, Núm. 1

  3. Recent Technical Developments in ASL: A Review of the State of the Art

    Magnetic Resonance in Medicine, Vol. 88, Núm. 5, pp. 2021-2042

  4. The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality

    The Lancet, Vol. 399, Núm. 10319, pp. 61-116

2021

  1. Author Correction: A community-based transcriptomics classification and nomenclature of neocortical cell types (Nature Neuroscience, (2020), 23, 12, (1456-1468), 10.1038/s41593-020-0685-8)

    Nature Neuroscience

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382